The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer
Open accessAbstract
Purpose: To update the recommendations for the use of tumor marker tests in the prevention, screening, treatment, and surveillance of gastrointestinal cancers. Methods: For the 2006 update, an update committee composed of members from the full Panel was formed to complete the review and analysis of data published since 1999. Computerized literature searches of Medline and the Cochrane Collaboration Library were performed. The Update Committee's literature review focused attention on available systematic reviews and meta-analyses of published tumor marker studies. Recommendations and Conclusion: For colorectal cancer, it is recommended that carcinoembryonic antigen (CEA) be ordered preoperatively, if it would assist in staging and surgical planning. Postoperative CEA levels should be performed every 3 months for stage II and III disease for at least 3 years if the patient is a potential candidate for surgery or chemotherapy of metastatic disease. CEA is the marker of choice for monitoring the response of metastatic disease to systemic therapy. Data are insufficient to recommend the routine use of p53, ras, thymidine synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, microsatellite instability, 18q loss of heterozygosity, or deleted in colon cancer (DCC) protein in the management of patients with colorectal cancer. For pancreatic cancer, CA 19-9 can be measured every 1 to 3 months for patients with locally advanced or metastatic disease receiving active therapy. Elevations in serial CA 19-9 determinations suggest progressive disease but confirmation with other studies should be sought. New markers and new evidence to support the use of the currently reviewed markers will be evaluated in future updates of these guidelines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728
Self-citationBoland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Self-citationFong, Y., Fortner, J., Sun, R. L., Brennan, M. F., & Blumgart, L. H. (1999) · Annals of Surgery · doi:10.1097/00000658-199909000-00004 · Cited by 3,715
Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., Chapelle, A. D. L., Ruschoff, J., Fishel, R., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,183
Self-citationMicrosatellite Instability in Cancer of the Proximal Colon
Thibodeau, S. N., Bren, G., & Schaid, D. (1993) · Science · doi:10.1126/science.8484122 · Cited by 3,130
Goldberg, R. M., Sargent, D. J., Morton, R. F., Fuchs, C. S., Ramanathan, R. K., Williamson, S. K., Findlay, B. P., Pitot, H. C., & Alberts, S. R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.046 · Cited by 2,249
Ribic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160
Self-citationSystematic Review of Microsatellite Instability and Colorectal Cancer Prognosis
Popat, S., Hubner, R., & Houlston, R. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.086 · Cited by 1,830
Nordlinger, B., Guiguet, M., Vaillant, J.-C., Balladur, P., Boudjema, K., Bachellier, P., Jaeck, D., & Association Française de Chirurgie (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960401)77:7<1254::aid-cncr5>3.0.co;2-i · Cited by 1,722
Tumor Microsatellite Instability and Clinical Outcome in Young Patients with Colorectal Cancer
Gryfe, R., Kim, H., Hsieh, E. T. K., Aronson, M. D., Holowaty, E. J., Bull, S. B., Redston, M., & Gallinger, S. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001133420201 · Cited by 1,388
Colorectal carcinoma antigens detected by hybridoma antibodies
Koprowski, H., Steplewski, Z., Mitchell, K., Herlyn, M., Herlyn, D., & Fuhrer, P. (1979) · Somatic Cell Genetics · doi:10.1007/bf01542654 · Cited by 1,364
Cunningham, D., Pyrhönen, S., James, R. D., Punt, C. J., Hickish, T. F., Heikkila, R., Johannesen, T. B., Starkhammar, H., Topham, C. A., Awad, L., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)02309-5 · Cited by 1,259
The Pezcoller lecture: cancer cell cycles revisited.
Sherr, C. J. (2000) · PubMed · Cited by 1,220
A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly Patients
Sargent, D. J., Goldberg, R. M., Jacobson, S. D., Macdonald, J. S., Labianca, R., Haller, D. G., Shepherd, L. E., Seitz, J. F., & Francini, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010957 · Cited by 986
Self-citationClinical Pharmacology of 5-Fluorouracil
Diasio, R. B., & Harris, B. E. (1989) · Clinical Pharmacokinetics · doi:10.2165/00003088-198916040-00002 · Cited by 969
Molecular Predictors of Survival after Adjuvant Chemotherapy for Colon Cancer
Watanabe, T., Wu, T.-T., Catalano, P. J., Ueki, T., Satriano, R., Haller, D. G., Benson, A. B., & Hamilton, S. R. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104193441603 · Cited by 888
Self-citationBast, R. C., Ravdin, P., Hayes, D. F., Bates, S., Fritsche, H., Jessup, J. M., Kemeny, N., Locker, G. Y., Mennel, R. G., & Somerfield, M. R. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1865 · Cited by 879
Self-citationKirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study
Andreyev, H. J. N., Norman, A. R., Cunningham, D., Oates, J., Dix, B. R., Iacopetta, B. J., Young, J., Walsh, T., Ward, R., Hawkins, N., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1964 · Cited by 872
Immunohistochemistry Versus Microsatellite Instability Testing in Phenotyping Colorectal Tumors
Lindor, N. M., Burgart, L. J., Leontovich, O. N., Goldberg, R. M., Cunningham, J. M., Sargent, D. J., Walsh-Vockley, C., Petersen, G. M., Walsh, M. D., Leggett, B., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.4.1043 · Cited by 817
Lothe, R. A., Peltomäki, P., Meling, G., Aaltonen, L. A., Nyström, M., Pylkkänen, L., Heimdal, K., Andersen, T. I., Møller, P., & Rognum, T. O. (1993) · PubMed · Cited by 778
Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers
Hayes, D. F., Bast, R. C., Desch, C. E., Fritsche, H., Kemeny, N. E., Jessup, J. M., Locker, G. Y., Macdonald, J. S., Mennel, R. G., Norton, L., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.20.1456 · Cited by 748
Self-citationDietmaier, W., Wallinger, S., Bocker, T., Kullmann, F., Fishel, R. A., & Rüschoff, J. (1997) · PubMed · Cited by 742
Allelic Loss of Chromosome 18q and Prognosis in Colorectal Cancer
Jen, J., Kim, H., Piantadosi, S., Liu, Z.-F., Levitt, R. C., Sistonen, P., Kinzler, K. W., Vogelstein, B., & Hamilton, S. R. (1994) · New England Journal of Medicine · doi:10.1056/nejm199407283310401 · Cited by 696
Self-citationPalliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis
Colorectal Cancer Collaborative Group (2000) · BMJ · doi:10.1136/bmj.321.7260.531 · Cited by 662
Scheithauer, W., Rosen, H., Kornek, G. V., Sebesta, C., & Depisch, D. (1993) · BMJ · doi:10.1136/bmj.306.6880.752 · Cited by 654
Renehan, A. G., Egger, M., Saunders, M. P., & O'Dwyer, S. T. (2002) · BMJ · doi:10.1136/bmj.324.7341.813 · Cited by 651
Follow-up strategies for patients treated for non-metastatic colorectal cancer
Jeffery, M., Hickey, B. E., Hider, P. N., & See, A. M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002200.pub3 · Cited by 640
(1990) · PubMed · Cited by 579
Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9.
Del Villano, B. C., Brennan, S., Brock, P., Bucher, C., Liu, V, McClure, M., Rake, B., Space, S., Westrick, B., Schoemaker, H., et al. (1983) · Clinical Chemistry · doi:10.1093/clinchem/29.3.549 · Cited by 506
Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil
van Kuilenburg, A. B. P. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.12.004 · Cited by 488
Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer
Carethers, J. M., Smith, E. J., Behling, C. A., Nguyen, L., Tajima, A., Doctolero, R. T., Cabrera, B. L., Goel, A., Arnold, C. A., Miyai, K., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.023 · Cited by 471
Popat, S., Matakidou, A., & Houlston, R. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.064 · Cited by 449
Moertel, C. G. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510080047030 · Cited by 449
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism
Peters, G. J., Backus, H. H. J., Freemantle, S., van Triest, B., Codacci-Pisanelli, G., van der Wilt, C. L., Smid, K., Lunec, J., Calvert, A. H., Marsh, S., et al. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00082-0 · Cited by 420
Samowitz, W. S., Curtin, K., Ma, K., Schaffer, D., Coleman, L. W., Leppert, M., & Slattery, M. L. (2001) · PubMed · Cited by 401
Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer.
Tempero, M. A., Uchida, E., Takasaki, H., Burnett, D. A., Steplewski, Z., & Pour, P. M. (1987) · PubMed · Cited by 400
Follow-up of patients with curatively resected colorectal cancer: a practice guideline
Figueredo, A., Rumble, R. B., Maroun, J., Earle, C. C., Cummings, B., McLeod, R., Zuraw, L., Zwaal, C., & the members of the Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care (2003) · BMC Cancer · doi:10.1186/1471-2407-3-26 · Cited by 392
Increasing incidence of primary brain lymphoma in the US
Eby, N. L., Grufferman, S., Flannelly, C. M., Schold, S. C., Vogel, F. S., & Burger, P. C. (1988) · Cancer · doi:10.1002/1097-0142(19881201)62:11 · Cited by 386
Microsatellite Instability and 8p Allelic Imbalance in Stage B2 and C Colorectal Cancers
Halling, K. C., French, A. J., McDonnell, S. K., Burgart, L. J., Schaid, D. J., Peterson, B. J., Moon-Tasson, L., Mahoney, M. R., Sargent, D. J., O'Connell, M. J., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.15.1295 · Cited by 375
Clinical utility of biochemical markers in colorectal cancer
Duffy, M. J., van Dalen, A., Haglund, C., Hansson, L., Klapdor, R., Lamerz, R., Nilsson, O., Sturgeon, C., & Topolcan, O. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00811-0 · Cited by 374
Stoehlmacher, J., Park, D. J., Zhang, W., Yang, D., Groshen, S., Zahedy, S., & Lenz, H.-J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601975 · Cited by 364
Nordic Gastrointestinal Tumor Adjuvant Therapy Group (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.6.904 · Cited by 356
(1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2843 · Cited by 353
Hemminki, A., Mecklin, J., Järvinen, H., Aaltonen, L. A., & Joensuu, H. (2000) · Gastroenterology · doi:10.1053/gast.2000.18161 · Cited by 352
Ahnen, D. J., Feigl, P., Quan, G., Fenoglio‐Preiser, C. M., Lovato, L., Bunn, P. A., Stemmerman, G. N., Wells, J. D., Macdonald, J. S., & Meyskens, F. L. (1998) · PubMed · Cited by 338
Self-citationGuidoboni, M., Gafà, R., Viel, A., Doglioni, C., Russo, A., Santini, A., Del Tin, L., Macrì, E., Lanza, G., Boiocchi, M., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61695-1 · Cited by 322
Pietra, N., Sarli, L., Costi, R., Ouchemi, C., Grattarola, M., & Peracchia, A. (1998) · Diseases of the Colon & Rectum · doi:10.1007/bf02239434 · Cited by 321
The DCC Protein and Prognosis in Colorectal Cancer
Shibata, D., Reale, M. A., Lavin, P., Silverman, M., Fearon, E. R., Steele, G., Jessup, J. M., Loda, M., & Summerhayes, I. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612053352303 · Cited by 308
Self-citationP53 abnormalities and outcomes in colorectal cancer: a systematic review
Munro, A. J., Lain, S., & Lane, D. P. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602358 · Cited by 289
Microsatellite instability and the role of hMSH2 in sporadic colorectalcancer.
Bubb, V., Curtis, L. J., Cunningham, C., Dunlop, M. G., Carothers, A. D., Rg, M., White, S., Bird, C. C., & Wyllie, A. H. (1996) · PubMed · Cited by 246
Metzger, R., Danenberg, K. D., Leichman, C. G., Salonga, D. S., Schwartz, E. L., Wadler, S., Lenz, H.-J., Groshen, S. G., Leichman, L., & Danenberg, P. V. (1998) · PubMed · Cited by 244
Lecomte, T., Ferraz, J.-M., Zinzindohoué, F., Loriot, M.-A., Tregouet, D.-A., Landi, B., Berger, A., Cugnenc, P.-H., Jian, R., Beaune, P., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0169 · Cited by 242
Zhou, X.-P., Hoang, J.-M., Li, Y.-J., Seruca, R., Carneiro, F., Sobrinho-Simoes, M., Lothe, R. A., Gleeson, C. M., Russell, S. E. H., Muzeau, F., et al. (1998) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199802)21:2<101::aid-gcc4>3.0.co;2-4 · Cited by 238
Johnston, P. G., Drake, J. C., Trepel, J. B., & Allegra, C. J. (1992) · PubMed · Cited by 226
Sporadic colorectal adenocarcinomas with high‐frequency microsatellite instability
Gafà, R., Maestri, I., Matteuzzi, M., Santini, A., Ferretti, S., Cavazzini, L., & Lanza, G. (2000) · Cancer · doi:10.1002/1097-0142(20001115)89:10<2025::aid-cncr1>3.3.co;2-j · Cited by 216
Wright, C. M., Dent, O. F., Barker, M., Newland, R. C., Chapuis, P. H., Bokey, E. L., Young, J. P., Leggett, B. A., Jass, J. R., & Macdonald, G. A. (2000) · Journal of British Surgery · doi:10.1046/j.1365-2168.2000.01508.x · Cited by 211
Survival and acquired genetic alterations in colorectal cancer
Laurent-Puig, P., Olschwang, S., Delattre, O., Remvikos, Y., Asselain, B., Melot, T., Validire, P., Muleris, M., Girodet, J., & Salmon, R. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)70006-w · Cited by 208
Elsaleh, H., Powell, B. L., McCaul, K. A., Grieu, F., Grant, R., Joseph, D., & Iacopetta, B. J. (2001) · PubMed · Cited by 204
SMAD4 as a Prognostic Marker in Colorectal Cancer
Alazzouzi, H., Alhopuro, P., Salovaara, R., Sammalkorpi, H., Järvinen, H., Mecklin, J.-P., Hemminki, A., Schwartz, S., Aaltonen, L. A., & Arango, D. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1458 · Cited by 202
Barratt, P., Seymour, M., Stenning, S., Georgiades, I., Walker, C., Birbeck, K., & Quirke, P. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11402-4 · Cited by 194
Ward, R. L., Cheong, K., Ku, S.-L., Meagher, A., O’Connor, T., & Hawkins, N. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.123 · Cited by 193
Follow-up of colorectal cancer: A meta-analysis
Rosen, M., Chan, L., Beart, R. W., Vukasin, P., & Anthone, G. (1998) · Diseases of the Colon & Rectum · doi:10.1007/bf02239433 · Cited by 192
Jakobsen, A., Nielsen, J. N., Gyldenkerne, N., & Lindeberg, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.219 · Cited by 191
Park, Y. J., Park, K. J., Park, J., Lee, K. U., Choe, K. J., & Kim, J. (1999) · World Journal of Surgery · doi:10.1007/pl00012376 · Cited by 182
Cawkwell, L., Gray, S., Murgatroyd, H., Sutherland, F., Haine, L., Longfellow, M., O’Loughlin, S., Cross, D., Kronborg, O., Fenger, C., et al. (1999) · Gut · doi:10.1136/gut.45.3.409 · Cited by 179
Graham, R. A., Wang, S., Catalano, P. J., & Haller, D. G. (1998) · Annals of Surgery · doi:10.1097/00000658-199807000-00009 · Cited by 176
Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator.
Ogunbiyi, O. A., Goodfellow, P. J., Herfarth, K., Gagliardi, G., Swanson, P. E., Birnbaum, E. H., Read, T. E., Fleshman, J. W., Kodner, I. J., & Moley, J. F. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.427 · Cited by 168
Ziske, C., Schlie, C., Gorschlüter, M., Glasmacher, A., Mey, U., Strehl, J., Sauerbruch, T., & Schmidt-Wolf, I. G. H. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601263 · Cited by 167
Tumor hypoxia in pelvic recurrences of cervical cancer
Höckel, M., Schlenger, K., Höckel, S., Aral, B., Schäffer, U., & Vaupel, P. W. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980821)79:4<390::aid-ijc14>3.0.co;2-9 · Cited by 163
Indicators for Treatment Strategies of Colorectal Liver Metastases
Ueno, H., Mochizuki, H., Hatsuse, K., Hase, K., & Yamamoto, T. (2000) · Annals of Surgery · doi:10.1097/00000658-200001000-00009 · Cited by 161
Chau, I., Allen, M. J., Cunningham, D., Norman, A. R., Brown, G. M., Ford, H. E. R., Tebbutt, N. C., Tait, D., Hill, M. E., Ross, P. J., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.041 · Cited by 156
Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer
Glimelius, B. L. G., Hoffman, K., Graf, W. D., et al. (1995) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a059157 · Cited by 151
Witzig, T. E., Loprinzi, C. L., Gonchoroff, N. J., Reiman, H. M., Cha, S. S., Wieand, H. S., Katzmann, J. A., Paulsen, J. K., & Moertel, C. G. (1991) · Cancer · Cited by 151
Genetic Tumor Markers With Prognostic Impact in Dukes’ Stages B and C Colorectal Cancer Patients
Diep, C. B., Thorstensen, L., Meling, G. I., Skovlund, E., Rognum, T. O., & Lothe, R. A. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.190 · Cited by 149
Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer
Martínez-López, E., Abad, A., Pous, A. F., Monzó, M., Ojanguren, I., Pifarré, À., Sánchez, J. J., Martín, C., & Rosell, R. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70423-8 · Cited by 148
Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?
Chen, C.-C., Yang, S.-H., Lin, J.-K., Lin, T.-C., Chen, W.-S., Jiang, J., Wang, H.-S., & Chang, S. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.08.013 · Cited by 143
Lima, C. M. S. R., Savarese, D., Bruckner, H., Dudek, A., Eckardt, J. R., Hainsworth, J., Yunus, F., Lester, E., Miller, W., Saville, W., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1182 · Cited by 142
Lanza, G., Gafà, R., Maestri, I., Santini, A., Matteuzzi, M., & Cavazzini, L. (2002) · Modern Pathology · doi:10.1097/01.mp.0000018979.68686.b2 · Cited by 132
Prognostic significance of allelic loss at chromosome 18q21 for stage II colorectal cancer
Carethers, J. M., Hawn, M. T., Greenson, J. K., Hitchcock, C. L., & Boland, C. R. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70424-x · Cited by 131
Garrity-Park, M. M., Burgart, L. J., Mahoney, M. R., Windschitl, H. E., Salim, M., Wiesenfeld, M., Krook, J. E., Michalak, J. C., Goldberg, R. M., O’Connell, M. J., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.042 · Cited by 126
Low Microsatellite Instability Is Associated With Poor Prognosis in Stage C Colon Cancer
Kohonen‐Corish, M. R. J., Daniel, J. J., Chan, C., Lin, B. P. C., Kwun, S. Y., Dent, O. F., Dhillon, V. S., Trent, R. J., Chapuis, P. H., & Bokey, E. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.109 · Cited by 117
Risio, M., Reato, G., di Celle, P. F., Fizzotti, M., Rossini, F. P., & Foà, R. (1996) · PubMed · Cited by 114
Renehan, A. G., O', S. T. D., & Whynes, D. K. (2004) · BMJ · doi:10.1136/bmj.328.7431.81 · Cited by 112
Parc, Y. R., Gueroult, S., Mourra, N., Serfaty, L., Fléjou, J., Tiret, E., & Parc, R. (2004) · Gut · doi:10.1136/gut.2003.019190 · Cited by 110
Microsatellite instability: impact on cancer progression in proximal and distal colorectal cancers
Jernvall, P., Mäkinen, M. J., Karttunen, T. J., Mäkelä, J. T., & Vihko, P. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00306-2 · Cited by 105
Choi, S., Lee, K. J., Bae, Y.-A., Min, K., Kwon, M.-S., Kim, K., & Rhyu, M. (2002) · PubMed · Cited by 100
Amaya, H., Tanigawa, N., Lu, C., Matsumura, M., Shimomatsuya, T., Horiuchi, T., & Muraoka, R. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)00280-2 · Cited by 99
Carcinoembryonic antigen screening: pros and cons.
Macdonald, J. S. (1999) · PubMed · Cited by 98
Self-citationApoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas.
Sinicrope, F. A., Hart, J. A. L., Hsu, H. A., Lemoine, M., Michelassi, F., & Stephens, L. C. (1999) · PubMed · Cited by 90
Lai, H., Sun, C., Yu, M., Chen, H., Liu, H.-S., & Chu, T. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991222)84:6<545::aid-ijc1>3.0.co;2-2 · Cited by 89
Matsuura, T., Kuratate, I., Teramachi, K., Osaki, M., Fukuda, Y., & Ito, H. (1999) · PubMed · doi:10.11501/3174649 · Cited by 85
Systematic review of genetic influences on the prognosis of colorectal cancer
Anwar, S., Frayling, I. M., Scott, N., & Carlson, G. (2004) · British journal of surgery · doi:10.1002/bjs.4737 · Cited by 83
Edmonston, T. B. (2000) · Human Pathology · doi:10.1053/hupa.2000.20383 · Cited by 81
Saw, R. P. M., Morgan, M., Koorey, D. J., Painter, D. M., Findlay, M. P. N., Stevens, G. N., Clarke, S. J., Chapuis, P. H., & Solomon, M. J. (2003) · Diseases of the Colon & Rectum · doi:10.1007/s10350-004-6524-2 · Cited by 81
Elsaleh, H., & Iacopetta, B. J. (2001) · Clinical Colorectal Cancer · doi:10.3816/ccc.2001.n.010 · Cited by 81
Carcinoembryonic antigen (CEA) in diagosis and prognosis of colorectal carcinoma
Arnaud, J., Koehl, C., & Adloff, M. (1980) · Diseases of the Colon & Rectum · doi:10.1007/bf02587615 · Cited by 78
Palmqvist, R., Engarås, B., Lindmark, G. E., Hallmans, G., Tavelin, B., Nilsson, O., Hammarström, S., & Hafström, L. (2003) · Diseases of the Colon & Rectum · doi:10.1007/s10350-004-6810-z · Cited by 74
Saito, M., Yamaguchi, A., Goi, T., Tsuchiyama, T., Nakagawara, G., Urano, T., Shiku, H., & Furukawa, K. (1999) · Oncology · doi:10.1159/000011954 · Cited by 71
Wang, C., van Rijnsoever, M., Grieu, F., Bydder, S. A., Elsaleh, H., Joseph, D. J., Harvey, J. M., & Iacopetta, B. J. (2003) · Oncology · doi:10.1159/000069311 · Cited by 65
Pous, A. F., Abad, A., Monzó, M., Sánchez, J. J., Guillot, M., Manzano, J. L., Piñol, M., Ojanguren, I., & Rosell, R. (2001) · Diseases of the Colon & Rectum · doi:10.1007/bf02234328 · Cited by 65
Wright, C. M., Dent, O. F., Newland, R. C., Barker, M., Chapuis, P. H., Bokey, E. L., Young, J. P., Leggett, B., Jass, J. R., & Macdonald, G. A. (2004) · Gut · doi:10.1136/gut.2003.034579 · Cited by 65
Loss of heterozygosity: An independent prognostic factor of colorectal cancer
Chang, S. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i6.778 · Cited by 62
Sun, X., Rütten, S., Zhang, H., & Nordenskjöld, B. A. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.6.1745 · Cited by 62
Transient CEA increase at start of oxaliplatin combination therapy for metastatic colorectal cancer
Sørbye, H., & Dahl, O. (2004) · Acta Oncologica · doi:10.1080/02841860410032380 · Cited by 56
CEA to Detect Recurrence of Colon Cancer
Northover, J. M. A. (1994) · JAMA · doi:10.1001/jama.1994.03520010041025 · Cited by 52
Prognostic and predictive relevance of microsatellite instability in colorectal cancer.
Storojeva, I., Boulay, J., Heinimann, K., Ballabeni, P., Terracciano, L., Laffer, U. T., Mild, G., Herrmann, R., & Rochlitz, C. F. (2005) · PubMed · Cited by 50
Curran, B., Lenehan, K., Mulcahy, H. E., Tighe, O., Bennett, M. A., Kay, E. W., O'Donoghue, D. P., Leader, M., & Croke, D. T. (2000) · Gut · doi:10.1136/gut.46.2.200 · Cited by 40
Genetic Alterations in Locally Advanced Stage II/III Colon Cancer: A Search for Prognostic Markers
Westra, J. L., Plukker, J. T. M., Buys, C. H. C. M., & Hofstra, R. M. W. (2004) · Clinical Colorectal Cancer · doi:10.3816/ccc.2004.n.024 · Cited by 37
DCC protein as a predictor of distant metastases after curative surgery for rectal cancer
Reymond, M. A., Dworak, O., Remke, S., Hohenberger, W., Kirchner, T., & Köckerling, F. (1998) · Diseases of the Colon & Rectum · doi:10.1007/bf02236264 · Cited by 35
Tsuji, T., Sawai, T., Takeshita, H., Nakagoe, T., Hidaka, S., Nanashima, A., Yamaguchi, H., Yasutake, T., Nagayasu, T., & Tagawa, Y. (2003) · Cancer Letters · doi:10.1016/j.canlet.2003.09.030 · Cited by 30
Thymidylate Synthase Gene Polymorphism as a Prognostic Factor for Colon Cancer
Suh, K. W., Kim, J. H., Kim, Y. B., Kim, J., & Jeong, S. (2005) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2004.09.030 · Cited by 29
Russo, A. D., Migliavacca, M., Zanna, I., et al. (2002) · PubMed · Cited by 28
Zauber, N. P., Wang, C., Lee, P. S., Redondo, T. C., Bishop, D. T., & Goel, A. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.017814 · Cited by 28
Geido, E., Sciutto, A., RUBAGOTTI, A., Oliani, C., Monaco, R., Risio, M., & Giaretti, W. (2002) · Cytometry · doi:10.1002/cyto.10109 · Cited by 27
Adjuvant radiochemotherapy of stage II and III rectal adenocarcinoma: role of CEA and CA 19-9.
Weißenberger, C., Plehn, G. V., Otto, F., Barke, A., Momm, F., & Geißler, M. (2005) · PubMed · Cited by 24
Borie, F., Daurès, J., Millat, B., & Trétarre, B. (2004) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2004.02.012 · Cited by 22
Microsatellite instability and MBD4 mutation in unselected colorectal cancer.
Evertson, S., Wallin, A., Arbman, G., Rütten, S., Emterling, A., Zhang, H., & Sun, X. (2003) · PubMed · Cited by 17
Mimori, K., Matsuyama, A., Yoshinaga, K., Yamashita, K., Masuda, T., Inoue, H., Ueo, H., & Mori, M. (2002) · Oncology · doi:10.1159/000065064 · Cited by 15
Grem, J. L. (2005) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.09.027 · Cited by 12
Nemunaitis, J. J., Cox, J. V., Hays, S., Meyer, W., Kebart, R., Ognoskie, N., Courtney, A., Yu, Y., Rasmussen, H. S., & Tong, A. (2000) · Cancer Investigation · doi:10.3109/07357900009031822 · Cited by 9
Cited by
Glycosylation in cancer: mechanisms and clinical implications
Pinho, S. S., & Reis, C. A. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3982 · Cited by 3,083
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
Melo, S. A., Luecke, L. B., Kahlert, C., Fernandez, A. F., Gammon, S. T., Kaye, J., LeBleu, V. S., Mittendorf, E. A., Weitz, J., Rahbari, N., et al. (2015) · Nature · doi:10.1038/nature14581 · Cited by 2,880
Pagès, F., Mlecnik, B., Marliot, F., Bindea, G., Ou, F.-S., Bifulco, C., Lugli, A., Zlobec, I., Rau, T. T., Berger, M. D., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30789-x · Cited by 2,075
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Bruni, D., Angell, H. K., & Galon, J. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0285-7 · Cited by 1,586
Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
Di Nicolantonio, F., Martini, M., Molinari, F., Sartore-Bianchi, A., Arena, S., Saletti, P., De Dosso, S., Mazzucchelli, L., Frattini, M., Siena, S., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.0786 · Cited by 1,591
Metadata
- Authors
- Locker, G. Y., Hamilton, S., Harris, J., Jessup, J. M., Kemeny, N., Macdonald, J. S., Somerfield, M. R., Hayes, D. F., & Bast, R. C.
- Venue
- Journal of Clinical Oncology
- Published
- 2006-11-20
- Volume
- 24
- Issue
- 33
- Pages
- 5313-5327
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2106489008
- Cited by
- 1,592
- References
- 121
- FWCI
- 30.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.